AGP Executive Report
Last update: 8 hours agoCancer Watch: Taiwan reported cancer as the No. 1 cause of death for the 44th straight year in 2025, with 199,576 total deaths and cancer still leading (54,838 deaths), followed by heart disease and pneumonia. Sports Medicine: Doctors in Taipei warn that World Cup energy is boosting soccer participation, but injuries are common—especially thigh, ankle, and knee problems—so warm-ups, conditioning, and recovery matter. Clinical Research: Kelun-Biotech’s sacituzumab tirumotecan (sac-TMT) plus osimertinib results were published in Cancer Cell, supporting a first-line strategy for EGFR-mutant NSCLC. Biotech Dealmaking: Antengene announced an exclusive global license with K2 Therapeutics for ATG-106 (CDH6 x CD3 bispecific TCE), with major upfront and milestone payments. Public Health Tech: New Taipei City launched a hornet hotspot warning system using a Line Bot and mapping from NTU to help residents avoid sting-risk zones. Healthcare Supply Chain: Pharmicell is described as the sole supplier of a key low-dielectric material used in AI-server circuit boards, with demand tied to Nvidia-linked production. Wellness & Food: Taiwan’s mangoes entered the French market, while nutrition guidance for festival foods like zongzi continues to circulate.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.